MCRB - Nestlé to buy microbiome therapy Vowst from Seres
2024-06-06 07:39:02 ET
More on Seres, Nestlé, etc.
- Nestle: Market Saturation And Cannibalization Problem
- Seres Therapeutics, Inc. (MCRB) Q1 2024 Earnings Call Transcript
- Nestlé S.A. (NSRGY) Q1 2024 Earnings Call Transcript
- Nestlé is the latest food giant to adjust to the GLP-1 phenomenon with a new brand
- Seres Therapeutics GAAP EPS of -$0.27 beats by $0.07